Pay in 4 interest-free payments of $29.75 Learn more
Ships within 48 hours · Estimated delivery Sep 18 - Sep 23
MCC950 reduces Interleukin-1p (IL-1β) production and attenuates the severity of experimental autoimmune encephalomyelitis (EAE)
gov/books/NBK548874/ PubMed PMID: 31644181
) pretreatment reduces myocardial damage in mice
Smiles: C[C@@]1(C[C@@H](O)[C@]2(O)C=CO[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]21)OC(=O)/C=C/C1C=CC=CC=1
5-b]pyridin-2-one
AH 23848 (calcium salt) Size:Contact [email protected] for quotation MCC950 reduces Interleukin-1p (IL-1β) productionAH 23848 (calcium salt) is a dual antagonist of TP1 and EP4 receptors . The thromboxane receptor (TP), also known as the prostanoid TP receptor, is activated by thromboxane A2 (TXA2). TXA2 is an exceptionally potent inducer of platelet aggregation and of contraction of vascular and respiratory smooth muscle . Prostaglandin E2 (PGE2) subtype receptors (EP) are involved in cellular proliferation and tumor development. Prostaglandin E2 (PGE2) activates
US$ 11.90
US$ 29.90
US$ 49.90
US$ 59.90
US$ 11.90